With this new webinar we want to answer this question

Why 3D tissue models and microfluidic systems are important for modeling healthy and leukemic lymphocytes dissemination in-vitro? Our guest speaker, Dr. Cristina Scielzo, will talk about her recent research in this topic, by adopting innovative approches like microgravity bioreactor and 3D printing; she will also present her preliminary results about the adoption of MIVO device for culturing lymphocytes.

Dr. Cristina Scielzo received her doctor degree in Medical Biotechnology at Università Vita-Salute San Raffaele and in 2012 obtained her PhD in Physiology at University of Milano. Since 2020 she is Group Leader of the Unit of Malignant B cell biology and 3D modelling at IRCCS Ospedale San Raffaele in the division of Experimental Oncology. She has published >40 articles in peer-reviewed journals. Her work has been cited > 3900 times, with an H-index of 31 and IF > 350.

Her team is currently studying the tumor cell/microenvironment interactions in chronic lymphocytic leukemia (CLL). In parallel, they are developing new advanced 3D in-vitro co-culture systems by prototyping a bench-top 3D bio-printer and exploiting different bioreactors with the goal to establish a 3D multi-organ system to dissect the leukemia/lymphoma-microenvironment cross-talk in the tissues.